General Information of This Metabolic Reaction (MR) (ID:
MR000932) |
Formula |
|
Reactant |
Ertugliflozin |
Product |
Ertugliflozin metabolite M2 |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 3A5 (CYP3A5)
|
DME Info
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
Metabolic Type
|
Conjugation
-
Glucuronidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes Drug Metab Dispos. 2020 Dec;48(12):1350-1363. doi: 10.1124/dmd.120.000171.
|
2 |
Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects Drug Metab Dispos. 2013 Feb;41(2):445-56. doi: 10.1124/dmd.112.049551.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.